← AtriCure, Inc. ATRC
Market Price
$44.30
Market Cap
$2.20B
P/E Ratio
N/A
Revenue (FY 2025)
↑14.9% YoY
$534.53M
3-Yr CAGR: 17.4%
Net Income
↑74.4% YoY
-$11.45M
Net Margin: -2.1%
Free Cash Flow
↑6,381.1% YoY
$48.28M
FCF Yield: 2.19%
EPS (Diluted)
↑74.7% YoY
$-0.24
Basic: $-0.24
Return on Equity
Efficiency
-2.3%
ROA: -115.1%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (ATRC)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2016 | $155.1M | — | $111.1M | $-33.3M | — | — | — | $-15.1M | $-22.8M | — |
| FY 2017 | $174.7M | +12.6% | $126.2M | $-26.9M | +19.3% | — | — | $-8.9M | $-15.3M | +32.8% |
| FY 2018 | $201.6M | +15.4% | $197.0M | $-21.1M | +21.4% | — | — | $-4.2M | $-10.4M | +32.3% |
| FY 2019 | $230.8M | +14.5% | $226.7M | $-35.2M | -66.5% | $-0.94 | — | $-15.8M | $-28.0M | -169.6% |
| FY 2020 | $206.5M | -10.5% | $201.6M | $-48.2M | -36.8% | $-1.14 | -21.3% | $-19.9M | $-25.1M | +10.2% |
| FY 2021 | $274.3M | +32.8% | $205.9M | $50.2M | +204.2% | $1.09 | +195.6% | $-13.8M | $-23.5M | +6.3% |
| FY 2022 | $330.4M | +20.4% | $245.9M | $-46.5M | -192.6% | $-1.02 | -193.6% | $-22.1M | $-39.0M | -65.8% |
| FY 2023 | $399.2M | +20.8% | $300.4M | $-30.4M | +34.5% | $-0.66 | +35.3% | $4.5M | $-7.5M | +80.7% |
| FY 2024 | $465.3M | +16.5% | $347.5M | $-44.7M | -46.8% | $-0.95 | -43.9% | $12.2M | $0.7M | +109.9% |
| FY 2025 | $534.5M | +14.9% | $400.8M | $-11.4M | +74.4% | $-0.24 | +74.7% | $57.3M | $48.3M | +6,381.1% |
Valuation
Market Price
$44.30
Market Cap
$2.20B
Enterprise Value
$2.10B
P/E Ratio
N/A
P/B Ratio
4.56
FCF Yield
2.19%
Dividend Yield
N/A
Shares Outstanding
Profitability & Margins
Gross Margin
74.98%
Operating Margin
-1.77%
Net Margin
-2.14%
Return on Equity (ROE)
-2.33%
Return on Assets (ROA)
-115.12%
Asset Turnover
53.75x
Revenue 3-Yr CAGR
17.40%
Financial Health & Liquidity
Current Ratio
0.19
Cash Ratio
3.15
Debt / Equity
0.126
Debt / Assets
6.221
Cash & Equivalents
$167.43M
Total Debt
$61.87M
Book Value / Share
$9.71
Cash Flow Efficiency
Operating Cash Flow
$57.33M
Capital Expenditures (CapEx)
$9.05M
Free Cash Flow
$48.28M
OCF / Revenue
10.73%
FCF / Revenue
9.03%
FCF 3-Yr CAGR
N/A
Per Share Metrics
EPS (Diluted)
$-0.24
EPS (Basic)
$-0.24
Dividends / Share
N/A
Book Value / Share
$9.71
EPS YoY Growth
74.74%
Balance Sheet (FY 2025)
Total Assets
$9.94M
Total Liabilities
$53.09M
Stockholders' Equity
$491.94M
Current Assets
$9.94M
Current Liabilities
$53.09M